array(3) { ["company_details"]=> array(13) { ["name"]=> string(26) "Natus Medical Incorporated" ["slug"]=> string(35) "05e48-us-natus-medical-incorporated" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/a15c3f67-a529-4950-a831-d87d6d0fff2a" ["description"]=> string(897) "Natus Medical Incorporated (Natus) offers medical equipment, software, supplies and services for the diagnosis, monitoring, and treatment of impairments and disorders effecting the brain, neural pathways, and eight sensory nervous systems. Our comprehensive product portfolio represents a heritage of innovation and leadership. Natus brands have been setting the standard for patient care for over eighty (80) years. Our products are trusted by medical professionals in university medical centers, hospitals, private practices, clinics and research laboratories around the world. Natus does not endorse personal/non-work related comments made by employees on social media. Further, Natus values the respect and inclusion of all people without regard to race, color, religion, sex, national origin, veteran status, disability, sexual orientation, gender identity, or any other protected status." ["address_street"]=> string(29) "6701 Koll Center Pkwy Ste 120" ["address_place"]=> string(10) "Pleasanton" ["address_region"]=> string(10) "California" ["founding_date"]=> string(10) "1987-02-13" ["website_domain"]=> string(9) "natus.com" ["website_url"]=> string(17) "https://natus.com" ["industry_codes"]=> array(1) { [0]=> string(47) "Electromedical and Electrotherapeutic Apparatus" } ["employee_count"]=> int(1480) ["article_count"]=> int(149) } ["articles"]=> array(1) { [0]=> array(7) { ["title_en"]=> string(47) "Natus Medical Stock Hits New 52-Week Low (BABY)" ["snippet_en"]=> string(242) "Natus Medical (Nasdaq:BABY) hit a new 52-week low Monday as it is currently trading at $9.03, below its previous 52-week low of $9.05 with 154,093 shares traded as of 2:30 p.m. ET. Average volume has been 347,600 shares over the past 30 days." ["url"]=> string(88) "https://www.thestreet.com/markets/natus-medical-stock-hits-new-52-week-low-baby-11266055" ["image_url"]=> string(78) "https://images.businessradar.com/articles/f0336af5-fcc4-4ba3-b6c2-d6588f7897dd" ["source"]=> string(13) "thestreet.com" ["publication_date"]=> string(10) "2011-10-03" ["categories"]=> array(3) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(14) "Issuing Shares" [2]=> string(12) "Stock Market" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(23) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(12) } [2]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(11) } [3]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(7) } [4]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(7) } [5]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(5) } [6]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(4) } [7]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(4) } [8]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(4) } [9]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(3) } [10]=> array(2) { ["name"]=> string(10) "Executives" ["count"]=> int(3) } [11]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(3) } [12]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(3) } [13]=> array(2) { ["name"]=> string(5) "SPACs" ["count"]=> int(3) } [14]=> array(2) { ["name"]=> string(11) "Name Change" ["count"]=> int(2) } [15]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(2) } [16]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(2) } [17]=> array(2) { ["name"]=> string(12) "Staff hiring" ["count"]=> int(2) } [18]=> array(2) { ["name"]=> string(10) "Downsizing" ["count"]=> int(2) } [19]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(2) } [20]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(2) } [21]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(2) } [22]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(2) } [23]=> array(2) { ["name"]=> string(22) "Shareholder Reputation" ["count"]=> int(2) } [24]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(1) } [25]=> array(2) { ["name"]=> string(17) "Business Disputes" ["count"]=> int(1) } [26]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(1) } [27]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(1) } [28]=> array(2) { ["name"]=> string(9) "Pollution" ["count"]=> int(1) } [29]=> array(2) { ["name"]=> string(17) "Production Issues" ["count"]=> int(1) } } } 05e48-us-natus-medical-incorporated

Natus Medical Incorporated

Location

California

Founded

1987-02-13

Website

https://natus.com

Articles

149 Articles

Category

Electromedical and Electrotherapeutic Apparatus

Description

Natus Medical Incorporated (Natus) offers medical equipment, software, supplies and services for the diagnosis, monitoring, and treatment of impairments and disorders effecting the brain, neural pathways, and eight sensory nervous systems. Our comprehensive product portfolio represents a heritage of innovation and leadership. Natus brands have been setting the standard for patient care for over eighty (80) years. Our products are trusted by medical professionals in university medical centers, hospitals, private practices, clinics and research laboratories around the world. Natus does not endorse personal/non-work related comments made by employees on social media. Further, Natus values the respect and inclusion of all people without regard to race, color, religion, sex, national origin, veteran status, disability, sexual orientation, gender identity, or any other protected status.

Articles

Natus Medical Stock Hits New 52-Week Low (BABY)

2011-10-03 (thestreet.com)

Natus Medical Stock Hits New 52-Week Low (BABY)

Natus Medical (Nasdaq:BABY) hit a new 52-week low Monday as it is currently trading at $9.03, below its previous 52-week low of $9.05 with 154,093 shares traded as of 2:30 p.m. ET. Average volume has been 347,600 shares over the past 30 days.

Read more

Newsletter subscription